Erweiterte Funktionen


Evaxion concludes Annual General Meeting




16.04.26 17:30
GlobeNewswire

COPENHAGEN, Denmark, April 16, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, held its Annual General Meeting today at the company’s offices.




zur Originalmeldung





 
 

Aktien des Tages

RSS Feeds




Bitte warten...